Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05219786 · ClinicalTrials.gov registry record · NA
Online Field Test of an Appendicitis Decision Support Tool
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 194
- Enrollment target
NCT05219786: Completed NA study, sponsored by University of Washington.
NCT05219786 is a NA study that has completed, run by University of Washington. The registered enrollment target is 194 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05219786, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
Study Summary
After the recent publication of the CODA Trial comparing antibiotics and surgery for acute appendicitis, the investigators developed a comprehensive decision support tool. This tool will help patients understand the risks and benefits of each treatment and make a treatment decision. This study is an online randomized field test comparing the decision support tool to a control infographic and assessing it's affect on decisional outcomes, such as decisional conflict.
Primary Outcome
Assessed using the validated decisional conflict scale comparing only participants in the intervention arm before and after viewing the decision support tool.
Interventions
- BEHAVIORAL Appendicitis Decision Support Tool
- BEHAVIORAL Control Infographic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2021-10-06 |
| Est. Completion | 2021-10-06 |
| Phase | NA |
What the finished NCT05219786 record still lists
NCT05219786 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Appendicitis Decision Support Tool is the first listed.
NCT05219786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05219786 about?
NCT05219786 is a clinical study titled "Online Field Test of an Appendicitis Decision Support Tool". After the recent publication of the CODA Trial comparing antibiotics and surgery for acute appendicitis, the investigators developed a comprehensive decision support tool. This tool will help patients understand the risks and benefits of each treatment and make a treatment decision. This study is an...
What is the current status of trial NCT05219786?
This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2021-10-06. Estimated completion is 2021-10-06.
What interventions are being tested in trial NCT05219786?
The interventions under investigation include: Appendicitis Decision Support Tool (BEHAVIORAL), Control Infographic (BEHAVIORAL).
Who is sponsoring clinical trial NCT05219786?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05219786's enrollment target sits among peer trials
194 568th of 2000 higher than 1,432 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI